Small Cell Lung Cancer

Small cell lung cancer (SCLC) accounts for about 20% of lung cancer, with high malignancy, short doubling time, early and extensive metastasis, sensitivity to chemotherapy and radiotherapy, high initial remission rate, but highly prone to secondary Drug resistance, easy to relapse, the main treatment is systemic chemotherapy. ?

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.